EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The development of opioid vaccines as a novel strategy for the treatment of opioid use disorder and overdose prevention

Mustafa Tuncturk iD, Shikha Kushwaha, Robin M Heider, Tyler Oesterle, Richard Weinshilboum, Ming-Fen Ho iD

International Journal of Neuropsychopharmacology · 2025

DOI: 10.1093/ijnp/pyaf005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Neuropsychopharmacology, 2025. Verfasst von Mustafa Tuncturk und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States. Hauptthemen laut MEDLINE: Opioid-Related Disorders, Vaccines, Analgesics, Opioid, Drug Overdose. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mayo Clinic Research Pipeline K2R Program, Terrance and Bette Noble Foundation, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Opioid use disorder (OUD) affects over 40 million people worldwide, creating significant social and economic burdens. Medication for opioid use disorder (MOUD) is often considered the primary treatment approach for OUD. MOUD, including methadone, buprenorphine, and naltrexone, is effective for some, but its benefits may be limited by poor adherence to treatment recommendations. Immunopharmacotherapy offers an innovative approach by using vaccines to generate antibodies that neutralize opioids, blocking them from crossing the blood-brain barrier and reducing their psychoactive effects. To date, only 3 clinical trials for opioid vaccines have been published. While these studies demonstrated the potential of opioid vaccines for relapse prevention, there is currently no standardized protocol for evaluating their effectiveness. We have reviewed recent preclinical studies that demonstrated the efficacy of vaccines targeting opioids, including heroin, morphine, oxycodone, hydrocodone, and fentanyl. These studies showed that vaccines against opioids reduced drug reinforcement, decreased opioid-induced antinociception, and increased survival rates against lethal opioid doses. These studies also demonstrated the importance of vaccine formulation and the use of adjuvants in enhancing antibody production and specificity. Finally, we highlighted the strengths and concerns associated with the opioid vaccine treatment, including ethical considerations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Opioid-Related DisordersVaccinesAnalgesics, OpioidDrug OverdoseOpiate OverdoseHumansAnimals

Stichwörter der Autor:innen

immunopharmacotherapyopioid use disordervaccine therapy

Substanzen

VaccinesAnalgesics, Opioid

Autor:innen und Institutionen

  • Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States.
  • Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, United States.

ORCID-Profile: Mustafa Tuncturk, Ming-Fen Ho

Förderung

  • Mayo Clinic Research Pipeline K2R Program
  • Terrance and Bette Noble Foundation
  • NIH HHS
  • AHRQ HHS
  • the Brain & Behavior Research Foundation
  • Mayo Clinic Center for Individualized Medicine
  • National Institutes of Health

Zitieren

APA

Tuncturk, M., Kushwaha, S., Heider, R. M., Oesterle, T., Weinshilboum, R., & Ho, M. F. (2025). The development of opioid vaccines as a novel strategy for the treatment of opioid use disorder and overdose prevention. International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyaf005

Vancouver

Tuncturk M, Kushwaha S, Heider RM, Oesterle T, Weinshilboum R, Ho MF. The development of opioid vaccines as a novel strategy for the treatment of opioid use disorder and overdose prevention. International Journal of Neuropsychopharmacology. 2025. doi:10.1093/ijnp/pyaf005

BibTeX
@article{Tuncturk2025,
  author = {Tuncturk, Mustafa and Kushwaha, Shikha and Heider, Robin M and Oesterle, Tyler and Weinshilboum, Richard and Ho, Ming-Fen},
  title = {The development of opioid vaccines as a novel strategy for the treatment of opioid use disorder and overdose prevention},
  journal = {International Journal of Neuropsychopharmacology},
  year = {2025},
  doi = {10.1093/ijnp/pyaf005}
}
Kostenlos starten →